[ad_1]
The Dutch government says the moratorium will last until at least March 29. They said those steps were taken as part of a precaution.
The BBC reports that Ireland has made a similar decision to the Netherlands, with reports of blood clots in some adults who have been vaccinated in Norway.
The World Health Organization (WHO), however, says that there is no link between the risk of blood clots and the risk of blood clots.
The European Medicines Agency (EMA) says the benefits of the vaccine “outweigh the risks.” The EMA is now reviewing whether the AstraZeneca vaccine causes blood clots, according to a BBC report.
AstraZeneca vaccines are now discontinued in Denmark, Norway, Bulgaria, Iceland, and Thailand.
The Dutch government said in a statement that it had decided to discontinue use of the estrogen vaccine as part of reports from Denmark and Norway on possible serious side effects from the vaccine.
“We don’t want any doubts about the vaccine. We have to make sure that everything is fine. Therefore, it is advisable to take a break for now,” said Dutch Health Minister Hukho Diora.
Sunday’s decision will delay the vaccination program in the Netherlands. The country’s authorities had ordered 12 million doses of the vaccine from AstraZeneca in advance; They also planned to administer 300,000 doses of the vaccine in the next two weeks.
In a statement, AstraZeneca said there was no evidence that its vaccine increased the risk of blood clots.
Of the people vaccinated so far in the European Union (EU) and the United Kingdom, only 15 cases of deep vein thrombosis (DVT) and 22 cases of pulmonary embolism have been reported.
“So far around 16 million people in the EU and UK have been vaccinated, with fewer reported blood clots, even less than the estimated number of blood clots in certain populations,” said Anne Taylor, chief medical officer of AstraZeneca.
[ad_2]
